| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/06/2008 | US20080057070 Antagonist Anti-Cd40 Monoclonal Antibodies and Methods for Their Use |
| 03/06/2008 | US20080057060 Method and system to remove cytokine inhibitor in patients |
| 03/06/2008 | US20080057034 enterobacter having a mutation in the fnr (fumarate nitrate reductase) gene and comprising a heterologous nucleotide sequence that codes a foreign antigen, used to induce an immune response against a heterologous antigen; vaccines |
| 03/06/2008 | US20080056991 Histamine H3 receptor inhibitors; (4-Azepan-1-ylmethyl-phenyl)-(4-isopropyl-piperazin-1-yl)-methanone dihydrochloride for example; allergies, nasal congestion, eating disorders, sleep disorders, neurodegenerative disorders |
| 03/06/2008 | CA2662196A1 Inhibitors of phosphatidylinositol 3-kinase |
| 03/06/2008 | CA2662174A1 Vaccines and methods for treatment or prevention of salmonella spp. bacterial infection in a vertebrate subject |
| 03/06/2008 | CA2662074A1 Triazole derivatives as kinase inhibitors |
| 03/06/2008 | CA2661850A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor containing the same |
| 03/06/2008 | CA2661803A1 Antibodies, assays and hybridomas |
| 03/06/2008 | CA2661782A1 Antagonistic human light-specific human monoclonal antibodies |
| 03/06/2008 | CA2660980A1 Pyrrolo isoquinolines as kinase inhibitors |
| 03/06/2008 | CA2660804A1 Reverse targeting lipid vesicle |
| 03/06/2008 | CA2660260A1 Use of modified interleukin-8 proteins |
| 03/06/2008 | CA2660175A1 Variable region sequences of il-31 monoclonal antibodies and methods of use |
| 03/05/2008 | EP1895005A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 03/05/2008 | EP1894931A1 Triazole derivatives as kinase inhibitors |
| 03/05/2008 | EP1894571A1 Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejection |
| 03/05/2008 | EP1893648A2 Antibodies against bacterial antigens and their use in the generation of immune response against apoptotic cells |
| 03/05/2008 | EP1893611A1 Ergoline derivatives and their use as chemokine receptor ligands |
| 03/05/2008 | EP1893591A1 POLYCYCLIC OXADIAZOLES OR I SOXAZOLES AND THEIR USE AS SlP RECEPTOR LIGANDS |
| 03/05/2008 | EP1893191A1 Medicinal acidic cannabinoids |
| 03/05/2008 | EP1575926B1 New pyridazin-3(2h)-one derivatives |
| 03/05/2008 | EP1560811B9 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 03/05/2008 | EP1368253B1 Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein |
| 03/05/2008 | EP1233969B1 Mono- and disaccharide derivatives |
| 03/05/2008 | EP1045836B1 Pyridones as src family sh2 domain inhibitors |
| 03/05/2008 | EP1030862B1 Viral clearance process |
| 03/05/2008 | EP1007720B1 Dendritic cell hybrids |
| 03/05/2008 | CN101137382A Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
| 03/05/2008 | CN101134108A Desonide cyclodextrin clathrate compound and method for preparing the same |
| 03/05/2008 | CN101134095A Traditional Chinese medicine composition for treating allergic rhinitis |
| 03/05/2008 | CN101134049A Donkey-hide gelatin powder for strengthening immunity and/or improving anaemia |
| 03/05/2008 | CN101134038A 缓释的口服给药组合物 The sustained-release composition for oral administration |
| 03/05/2008 | CN101134034A Immunological enhancement medicine and method for preparing the same |
| 03/05/2008 | CN101134016A Recombination human body CD25-resist inosculated monoclone antibody liquid injection and method of manufacturing the same |
| 03/05/2008 | CN101133899A Health-care cigarettes |
| 03/05/2008 | CN100372849C Pyrrolo pyrimidine compounds as inhibitor of cysteine protease |
| 03/05/2008 | CN100372847C Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via novel 1H-imidazo [4,5-C] quinolin-4-cyano and 1H-imidazo [4,5-C] quinolin-4-carboxamide intermediates |
| 03/05/2008 | CN100372846C Sulfonamido substituted imidazopyridines |
| 03/05/2008 | CN100372836C Immunotherapeutic imides/amides |
| 03/04/2008 | US7339047 Comprises nucleotide sequences coding interleukin-1b converting enzyme ligand for use in diagnosis, prevention and treatment of autoimmune, connective tissue and crohn's diseases |
| 03/04/2008 | US7339038 Heparanase specific molecular probes and their use in research and medical applications |
| 03/04/2008 | US7338659 Reducing immunogenicities of immunoglobulins by framework-patching |
| 03/04/2008 | US7338658 Chimeric antibody specific to human CD4 which comprises the variable heavy and light chain sequences of an Old World monkey monoclonal antibody produced against human CD4 and human constant heavy and light domain sequences |
| 03/04/2008 | US7338653 Amino-terminally truncated MCP-2 as chemokine antagonists |
| 03/01/2008 | CA2598060A1 Methods and compositions for the treatment and prevention of cancer |
| 02/28/2008 | WO2008025031A1 Treatment of graft-versus-host disease |
| 02/28/2008 | WO2008024196A1 Chemical compounds |
| 02/28/2008 | WO2008023818A1 Fiber and method for production of fiber |
| 02/28/2008 | WO2008023783A1 Amine compound |
| 02/28/2008 | WO2008023665A1 Bacterial strain having anti-allergic activity and immunostimulating activity, and beverage, food, anti-allergic agent and immunostimulating agent comprising the bacterial strain |
| 02/28/2008 | WO2008023664A1 Bacterial strain having anti-allergic activity, and beverage, food and anti-allergic agent comprising the bacterial strain |
| 02/28/2008 | WO2008023663A1 Bacterial strain having anti-allergic activity, and beverage, food and anti-allergic agent comprising cell of the bacterial strain |
| 02/28/2008 | WO2008023662A1 Bacterial strain having immunostimulating activity, and beverage, food and immunostimulating agent comprising the bacterial strain |
| 02/28/2008 | WO2008022557A1 Liquid composition of sirolimus |
| 02/28/2008 | WO2008022468A1 Compositions and methods for treating myelosuppression |
| 02/28/2008 | WO2008022444A1 Small cationic antimicrobial peptides |
| 02/28/2008 | WO2008022390A1 Anti-c5ar antibodies with improved properties |
| 02/28/2008 | WO2008007123A3 Pharmaceutical compounds |
| 02/28/2008 | WO2007147623A3 A novel target in the treatment of cytokine release syndrome |
| 02/28/2008 | WO2007122392A8 Composition comprising a cytotoxic t-cell - inducing adjuvant |
| 02/28/2008 | WO2007110678A3 Neutralizing antibodies and methods of use thereof |
| 02/28/2008 | WO2007090569A8 Conditioned blood composition and method for its production |
| 02/28/2008 | WO2007064846A3 COMPOSITIONS AND METHODS OF USING siRNA TO KNOCKDOWN GENE EXPRESSION AND TO IMPROVE SOLID ORGAN AND CELL TRANSPLANTATION |
| 02/28/2008 | US20080051464 Protein phosphatase inhibitors |
| 02/28/2008 | US20080051451 Autoimmune conditions and NADPH oxidase defects |
| 02/28/2008 | US20080051404 Heteroaryl compounds useful as inhibitors of E1 activating enzymes |
| 02/28/2008 | US20080051397 with polyglycolized glyceride (macrogol glyceride); Gelucires"; multiple sclerosis, asthma, scleroderma, endometriosis; 1,3-benzothiazol-2(3H)-ylidene{2-[(1,4-dimethylpiperazin-2-yl)methoxy]pyrimidin-4-yl}acetonitrile; adding to melt as powder under stirring resulting in homogeneous molten dispersion |
| 02/28/2008 | US20080051389 mimetics of the Smac peptide, used for the treatment of cancer and autoimmune disorders |
| 02/28/2008 | US20080051376 Method for Producing Albumin-Corticoid Conjugates |
| 02/28/2008 | US20080051359 Antisense oligonucleotide modulation of stat3 expression |
| 02/28/2008 | US20080051349 Peptide antagonists of zonulin and methods for use of the same |
| 02/28/2008 | US20080051339 Modulators of pharmacological agents |
| 02/28/2008 | US20080051332 Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone |
| 02/28/2008 | US20080051324 Medium-Chain Length Fatty Alcohols as Stimulators of Hematopoiesis |
| 02/28/2008 | US20080050751 Nonhuman model animal of th2-mediated hyperimmune response |
| 02/28/2008 | US20080050460 Uses of lectin-conotoxin |
| 02/28/2008 | US20080050434 Novel Composition for Topical Delivery |
| 02/28/2008 | US20080050421 Methods for reducing neovascularization or edema |
| 02/28/2008 | US20080050420 Methods for reducing neovascularization or edema |
| 02/28/2008 | US20080050406 Modified Dermatophagoides pteronyssinus allergen Der p 5 protein which inhibits immunoglobulin E (IgE) binding when exposed again to the antigen; treating allergies |
| 02/28/2008 | US20080050403 Production of viruses, viral isolates and vaccines |
| 02/28/2008 | US20080050392 Administration of an activated form of ultra-low doses of antibodies to an antigen, obtained using homeopathic techniques; drug dependence/drug withdrawal; side effect reduction |
| 02/28/2008 | US20080050391 Method for Treating Autoimmune Diseases With Antibodies |
| 02/28/2008 | US20080050371 Comprises immunoglobulin for treating and preventing inflammation, thrombocytopenia and/or autoimmune hemolytic anemia |
| 02/28/2008 | US20080050368 Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 02/28/2008 | US20080050365 Anti-Hiv Antibody |
| 02/28/2008 | US20080050360 Method of treating a pathological syndrome and a pharmaceutical agent |
| 02/28/2008 | US20080050317 Oleaginous pharmaceutical and cosmetic foam |
| 02/28/2008 | DE19955576B4 Transferverbindungen, ihre Herstellung und ihre Verwendung Transfer compounds, their preparation and their use |
| 02/28/2008 | CA2661924A1 Treatment of graft-versus-host disease |
| 02/28/2008 | CA2661381A1 Bacterial strain having anti-allergic activity, and beverage, food and anti-allergic agent comprising cell of the bacterial strain |
| 02/28/2008 | CA2661292A1 Compositions and methods for treating myelosuppression |
| 02/28/2008 | CA2660690A1 Treatment of fibrosing disorders |
| 02/28/2008 | CA2660668A1 Small cationic antimicrobial peptides |
| 02/28/2008 | CA2660156A1 Anti-c5ar antibodies with improved properties |
| 02/28/2008 | CA2658000A1 Use of cd83 in combination therapies |
| 02/28/2008 | CA2648521A1 1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-n0r-vitamin d compounds with a 1,1-dimethylpropyl side chain |
| 02/27/2008 | EP1892297A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 02/27/2008 | EP1892251A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |